ArticlePLOS digital health2026
Predicting multiple sclerosis from radiologically isolated syndrome using generative artificial intelligence.
Article in PLOS digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiologically Isolated Syndrome (RIS) is characterized by incidental MRI findings indicative of multiple sclerosis (MS) in asymptomatic individuals. Factors such as younger age, positive cerebrospinal fluid biomarkers, and specific lesion locations have been previously linked to a higher risk of conversion from RIS to clinical MS. Predicting which individuals will develop clinical MS remains challenging. Based on widely available cross-sectional patient studies, unsupervised machine learning has been proposed to uncover MRI-driven MS phenotypes with distinct temporal progression patterns. We evaluated whether an unsupervised artificial intelligence framework based on generative manifold learning could stratify RIS patients by conversion risk. BrainGML-MS analyzed imaging biomarkers and generated individualized digital twins from MRI data. We studied 152 RIS individuals (32 converters, RIS-C), 152 MS patients, and 152 healthy controls. The model identified four RIS clusters with distinct five-year conversion risks ranging from 10% to 39%. The brain age gap increased progressively from healthy controls to RIS non-converters, RIS-C, and MS. RIS converters showed greater structural atrophy and greater similarity to MS profiles. These findings indicate that MRI-derived brain aging biomarkers and structural deviations measured at the first RIS scan may improve early risk stratification and support clinical decision-making in preclinical MS.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.